search
Back to results

Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise (DYNAMMO-T2DEX)

Primary Purpose

Insulin Resistance, Diabetes

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
exercise
Sponsored by
Pennington Biomedical Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Insulin Resistance, Diabetes focused on measuring Mitochondrial Dynamics, Insulin Resistance, Exercise and Diabetes

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 2 Diabetes
  • Body Mass Index (BMI) between 25 and 40 kg
  • HbA1C < 8.5%
  • sedentary

Exclusion Criteria:

  • pharmacotherapy for diabetes
  • smoking

Sites / Locations

  • Pennington Biomedical Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

exercise

standard of care

Arm Description

12 week exercise program, 5 days/week, 60 min/day

12 week standard of care recommendations

Outcomes

Primary Outcome Measures

Effects of exercise on mitochondrial dynamics
Dynamics will be assessed from quantitative measures of dynamin-related protein-1.

Secondary Outcome Measures

Effects of exercise on mitochondrial function
Function will be assessed from oxygen consumption.
Insulin sensitivity
Insulin sensitivity will be assessed by euglycemic hyperinsulinemic clamp.

Full Information

First Posted
November 28, 2016
Last Updated
September 11, 2023
Sponsor
Pennington Biomedical Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02977442
Brief Title
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise
Acronym
DYNAMMO-T2DEX
Official Title
Dynamics of Muscle Mitochondria in Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 2016 (undefined)
Primary Completion Date
September 2023 (Actual)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Pennington Biomedical Research Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Insulin promotes the clearance of sugars from the blood into skeletal muscle and fat cells for use as energy; it also promotes storage of excess nutrients as fat. Type 2 diabetes occurs when the cells of the body become resistant to the effects of insulin, and this causes high blood sugar and contributes to a build-up of fat in muscle, pancreas, liver, and the heart. Understanding how insulin resistance occurs will pave the way for new therapies aimed at preventing and treating type 2 diabetes. Mitochondria are cellular structures that are responsible for turning nutrients from food, into the energy that our cells run on. As a result, mitochondria are known as "the powerhouse of the cell." Mitochondria are dynamic organelles that can move within a cell to the areas where they are needed, and can fuse together to form large, string-like, tubular networks or divide into small spherical structures. The name of this process is "mitochondrial dynamics" and the process keeps the cells healthy. However, when more food is consumed compared to the amount of energy burned, mitochondria may become overloaded and dysfunctional resulting in a leak of partially metabolized nutrients that can interfere with the ability of insulin to communicate within the cell. This may be a way for the cells to prevent further uptake of nutrients until the current supply has been exhausted. However, long term overload of the mitochondria may cause blood sugar levels to rise and lead to the development of type 2 diabetes. This study will provide information about the relationship between mitochondrial dynamics, insulin resistance and type 2 diabetes.
Detailed Description
The traditional view of mitochondria as isolated, spherical, energy producing organelles is undergoing a revolutionary transformation. Emerging data show that mitochondria form a dynamic networked reticulum that is regulated by cycles of fission and fusion. The discovery of a number of proteins that regulate these activities has led to important advances in understanding human disease. Data show that activation of dynamin related protein 1 (Drp1), a protein that controls mitochondrial fission, is reduced following exercise in prediabetes, and the decrease is linked to increased insulin sensitivity and fat oxidation. The proposed research will test the hypothesis that mitochondrial dynamics is a key mechanism of insulin resistance in type 2 diabetes. The experimental approach harnesses innovative molecular and cellular tools, interfaced with physiologically significant human studies to obtain meaningful data on insulin resistance, and has the potential to generate insights that will lead to new diabetes therapies for future generations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance, Diabetes
Keywords
Mitochondrial Dynamics, Insulin Resistance, Exercise and Diabetes

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
24 (Actual)

8. Arms, Groups, and Interventions

Arm Title
exercise
Arm Type
Experimental
Arm Description
12 week exercise program, 5 days/week, 60 min/day
Arm Title
standard of care
Arm Type
No Intervention
Arm Description
12 week standard of care recommendations
Intervention Type
Behavioral
Intervention Name(s)
exercise
Primary Outcome Measure Information:
Title
Effects of exercise on mitochondrial dynamics
Description
Dynamics will be assessed from quantitative measures of dynamin-related protein-1.
Time Frame
5 years
Secondary Outcome Measure Information:
Title
Effects of exercise on mitochondrial function
Description
Function will be assessed from oxygen consumption.
Time Frame
5 years
Title
Insulin sensitivity
Description
Insulin sensitivity will be assessed by euglycemic hyperinsulinemic clamp.
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 Diabetes Body Mass Index (BMI) between 25 and 40 kg HbA1C < 8.5% sedentary Exclusion Criteria: pharmacotherapy for diabetes smoking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Kirwan, PhD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pennington Biomedical Research Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise

We'll reach out to this number within 24 hrs